Showing 1-10 of 28 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| FAME-1 Eye Trial Completion | The University of Sydney | Alicia Jenkins | Improving Lives | 01-July-2025 to 30-June-2028 | $545.454,35 |
| Providing blood glucose monitoring, HbA1c testing, and other in-country support to centers enrolled in the Life for a Child Program | Diabetes Australia (fka Diabetes New South Wales) | Graham Ogle | Transportfolio | 01-March-2025 to 28-February-2026 | $800.000,00 |
| End Diabetes Stigma: Global Summit | Deakin University | Jane Speight | Improving Lives | 01-March-2025 to 28-February-2027 | $500.000,00 |
| Experiences of children with early-stage T1D and their families in three Australian monitoring cohorts: what matters most for engagement in a national program? | The University of Adelaide | Jennifer Couper | Cures | 01-February-2025 to 31-January-2027 | $179.817,84 |
| A synergistic approach to preventing islet allograft rejection in beta cell replacement therapy | St. Vincent's Institute of Medical Research | Seigmund Lai | Cures | 01-March-2025 to 29-February-2028 | $256.285,00 |
| Engineering an artificial pancreas in the gut for the treatment of diabetes | Monash University | Rong Xu | Improving Lives | 01-September-2025 to 31-August-2028 | $285.000,00 |
| Improving Glucose Levels while Preventing Ketoacidosis in People with Type 1 Diabetes Receiving SGLT1/2 inhibitor Therapy Using a Novel Continuous Ketone Sensor (PARTNER) | The University of Melbourne | David O'Neal | Improving Lives | 01-November-2024 to 31-October-2026 | $221.126,00 |
| A simple assay to monitor autoimmune T cell responses in T1D | St. Vincent's Institute of Medical Research | Stuart Mannering | Cures | 01-November-2024 to 31-October-2025 | $122.849,00 |
| Investigating the utility of urine C-peptide in early-stage T1D | The University of Adelaide | Jennifer Couper | Cures | 01-September-2024 to 31-August-2025 | $93.760,34 |
| Using Multi-omics to turn islet autoimmunity driver genes into therapies | The University of Adelaide | Simon Barry | Cures | 01-August-2024 to 31-July-2027 | $446.624,00 |